本页面由Tiger Trade Technology Pte. Ltd.提供服务

Applied Therapeutics Inc.

0.1030
0.0000
成交量:- -
成交额:- -
市值:1,486.30万
市盈率:-0.83
高:0.1030
开:0.1030
低:0.1030
收:0.1030
52周最高:1.50
52周最低:0.0900
股本:1.44亿
流通股本:1.20亿
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.1236
每股收益(LYR):-0.7570
净资产收益率:-680.47%
总资产收益率:-88.35%
市净率:-26.49
市盈率(LYR):-0.14

数据加载中...

2026/02/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/02/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/02/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/02/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/02/03

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/02/03

重要事件披露

Form 8-K - Current report
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

重要事件披露

Form 8-K - Current report
2025/11/20

重要事件披露

Form 8-K - Current report
2025/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/13

重要事件披露

Form 8-K - Current report
2025/08/29

重要事件披露

Form 8-K - Current report
2025/08/14

重要事件披露

Form 8-K - Current report
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report
2025/08/12

重要事件披露

Form 8-K - Current report
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/12

重要事件披露

Form 8-K - Current report
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/14

重要事件披露

Form 8-K - Current report